Aptose Biosciences Inc.

NASDAQ:APTO

0.25 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Operating Activities:
Net Income -51.207-41.823-65.354-55.238-26.277-28.868-11.661-13.858-10.54-11.503-9.726-5.399-4.478-5.1575.053-8.128-6.37-9.012-16.265-17.582-22.241-12.119-8.825-9.895-5.739-3.12-3.227-3.483
Depreciation & Amortization 0.4660.5280.6220.6140.6130.0870.0840.1150.0690.0330.0190.0370.0430.0570.0820.1730.3191.0912.2061.8681.591.4822.4232.4081.7770.3390.2750.363
Deferred Income Tax 00-0.007-0.008-0.0230.025-0.0070.227-0.66900-04.4785.157-5.053-0.413000000000000
Stock Based Compensation 3.6535.20712.94921.4382.2964.2760.8171.5052.0262.408000.001000000000000000
Change In Working Capital 2.4494.3171.516-0.2621.8880.6730.544-0.1350.163-0.533-0.013-0.051.584-1.4721.569-0.864-0.798-0.29-0.42-0.929-0.0951.471-1.3911.2020.3840.47500.508
Accounts Receivables 0000000000000000000000000000
Inventory 0000000000000000000000000000
Accounts Payables 04.627-0.4720.2110.6450.726000.1920-0.0590.3790.104-0.1760.083-0.572000000000000
Other Working Capital 2.449-0.311.988-0.4731.243-0.0530.564-0.136-0.029-0.5330.046-0.431.48-1.2961.485-0.292000-0.929-0.0951.471-1.3911.20200.47500.508
Other Non Cash Items 0.049-0.5516.97-0.435-0.0550.6-0.068-0.078-0.175-0.3480.17-0.023-4.458-5.157-5.3432.206-3.4022.3272.6131.7240.1480.491-00.0010-0.136-0.0690
Operating Cash Flow -44.59-32.322-43.304-33.891-21.558-23.207-10.291-12.225-9.126-9.943-7.867-4.938-2.34-6.034-3.527-6.617-10.251-5.884-11.866-14.919-20.598-8.676-7.793-6.284-3.579-2.442-3.021-2.612
Investing Activities:
Investments In Property Plant And Equipment -0.029-0.024-0.212-0.079-0.102-0.329-0.013-0.004-0.238-0.302-0.0200-0.008-0.002-0.161-0.058-0.019-0.068-0.477-0.281-0.918-0.312-0.112-3.790-0.1370
Acquisitions Net 000000000000000000000000-0.36000
Purchases Of Investments 00-34.9960-17.2680-0.798000-10.155000000-5.01700-1.05500-26.2610-5.290-5.66
Sales Maturities Of Investments 030.09-34.99612.707-17.2680.34106.1345.718000000.2375.7834.213011.8575.558006.1370003.2950
Other Investing Activites 9.9890.0334.9960.01317.26800.0680.0780.206-7.2270.070.02900.253-00-0.0010-00-0.0019.06100.0010.0770-0.4810
Investing Cash Flow 9.9630.066-35.20812.628-17.370.012-0.7436.2095.686-7.529-10.1050.02900.2450.2355.6224.154-5.03611.7895.081-1.3378.1445.825-26.372-4.072-5.292.677-5.66
Financing Activities:
Debt Repayment 0000000000.5530.55300.873-1.032-3.337000010.318000002.306-1.9912.467
Common Stock Issued 6.8810.1010.03658.40293.16725.720.55.7260.008030.2845.9361.7696.0392.1683.4937.60410.89700.87922.0560.5210.9091.34334.4334.8151.9915.152
Common Stock Repurchased 0000000000000000000000000000
Dividends Paid 0000000000000000000000000000
Other Financing Activities 0.0290.0150.190.40510.2812.15113.218-4.7440.7779.5154.381-0.713-0.0030.0500-0.253-1.1800.0060-0.178006.34801.9910
Financing Cash Flow 6.910.1160.22658.807103.44827.87113.7185.6180.70810.06735.2195.2311.7666.039-1.173.4937.3519.716011.19722.0560.3430.9091.34340.7817.1211.9917.619
Other Information:
Effect Of Forex Changes On Cash 0.002-0.0040.0070.0070.023-0.0080.007-0.2270.6690.0250000000.0010.0010-00.001-00.001-0.00100-1.991-0
Net Change In Cash -27.718-2.144-78.27937.55164.5434.6682.691-0.626-2.06217.20417.2470.323-0.5740.25-4.4612.4971.255-1.203-0.0761.3590.122-0.189-1.059-31.31433.13-0.61-0.343-0.653
Cash At End Of Period 9.25236.9739.114117.39379.84215.29910.6317.9328.28917.83517.8480.6340.3110.9330.6324.932.6671.3132.4452.2120.7860.660.7621.8133.9891.2210.8921.306